Early intervention and the avoidance or delay of progression to type 2 diabetes is of enormous benefit to patients in terms of increasing life expectancy and quality of life, and potentially in economic terms for society and health-care payers.
To address the growing impact of type 2 diabetes, the International Diabetes Federation (IDF) Taskforce on Epidemiology and Prevention convened a consensus workshop in 2006. The resulting consensus paper was launched at the 2nd International Congress on Prediabetes and the Metabolic Syndrome in Barcelona in April 2007 and published in the May 2007 issue of Diabetic Medicine. The primary goal of the workshop and the paper is the prevention of type 2 diabetes in both the developed and the developing world.
- Highlights of the IDF Consensus
- Download the IDF Consensus (pdf, 258KB), published in the May issue of Diabetic Medicine